Prolonged mild hyperglycemia induces vagally mediated compensatory increase in C-Peptide secretion in humans.
about
Cephalic phase pancreatic polypeptide responses to liquid and solid stimuli in humans.48-h glucose infusion in humans: effect on hormonal responses, hunger and food intake.Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism.Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesityCentral control of body weight and appetite.Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease.Visceral nerves: vagal and sympathetic innervation.The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.How neural mediation of anticipatory and compensatory insulin release helps us tolerate food.Atypical antipsychotic-induced weight gain: insights into mechanisms of action.Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice.Effects of genetic severity on glucose homeostasis in Friedreich ataxiaHypothalamic Dysfunction in Obesity and Metabolic Disorders.Contribution of parasympathetic muscarinic augmentation of insulin secretion to olanzapine-induced hyperinsulinemia.C-peptide modifies leptin and visfatin secretion in human adipose tissue.Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance.Testing the plasticity of insulin secretion and β-cell functionin vivo: responses to chronic hyperglycaemia in the sheep
P2860
Q33711005-E3837C9A-4FB1-41C7-A034-9C3997B436AEQ33712917-B5406BFD-E02D-44AC-A606-7090D88B703AQ35115972-B52CD710-5DDA-44EC-B2CE-B0DE26E8AC99Q36053107-07AA59FE-5BE7-46B1-9E55-7D00E1B9887AQ36842563-1CF46206-01F5-41D5-ACFA-F58538CA9E52Q36979763-FF1E3BEB-8F36-496D-A476-9503F9B0A507Q37110540-6BF472BE-8233-4631-9265-1FB2E7D1CA27Q37254774-73665525-5061-44FE-8C2B-ADD841CAE5D9Q37399121-8AE85897-2F58-409F-808F-08137CED7744Q37831550-DACB9E72-9556-4BA8-9856-A39AB610622BQ37963571-B664F920-1CBE-4E49-A5AD-8EE63C12246EQ38329197-BE2D79B3-C982-4D8D-8465-5B59DA800BE2Q42859119-DA4BDB39-ADBE-4D3A-BE21-3541046A1889Q47762981-4E4A628C-1088-4FFA-B64E-2ED17896FD58Q49917593-44561B4A-ACE8-48FF-9706-BA29B25AFEBDQ55053916-7F8EA43E-E3DF-49FD-9813-477EF1BC9869Q55267184-2EF87303-7EF2-4475-A415-E08EDC9E0E86Q57692348-468D16D5-D5CE-4DAC-879B-E9CC19E3F726
P2860
Prolonged mild hyperglycemia induces vagally mediated compensatory increase in C-Peptide secretion in humans.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Prolonged mild hyperglycemia i ...... C-Peptide secretion in humans.
@en
Prolonged mild hyperglycemia i ...... C-Peptide secretion in humans.
@nl
type
label
Prolonged mild hyperglycemia i ...... C-Peptide secretion in humans.
@en
Prolonged mild hyperglycemia i ...... C-Peptide secretion in humans.
@nl
prefLabel
Prolonged mild hyperglycemia i ...... C-Peptide secretion in humans.
@en
Prolonged mild hyperglycemia i ...... C-Peptide secretion in humans.
@nl
P356
P1476
Prolonged mild hyperglycemia i ...... C-Peptide secretion in humans.
@en
P2093
Karen L Teff
Raymond R Townsend
P304
P356
10.1210/JC.2003-032094
P407
P577
2004-11-01T00:00:00Z